文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

m6A 中心调控疾病发生发展和药物反应

M6AREG: m6A-centered regulation of disease development and drug response.

机构信息

Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.

Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 169610, Singapore.

出版信息

Nucleic Acids Res. 2023 Jan 6;51(D1):D1333-D1344. doi: 10.1093/nar/gkac801.


DOI:10.1093/nar/gkac801
PMID:36134713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9825441/
Abstract

As the most prevalent internal modification in eukaryotic RNAs, N6-methyladenosine (m6A) has been discovered to play an essential role in cellular proliferation, metabolic homeostasis, embryonic development, etc. With the rapid accumulation of research interest in m6A, its crucial roles in the regulations of disease development and drug response are gaining more and more attention. Thus, a database offering such valuable data on m6A-centered regulation is greatly needed; however, no such database is as yet available. Herein, a new database named 'M6AREG' is developed to (i) systematically cover, for the first time, data on the effects of m6A-centered regulation on both disease development and drug response, (ii) explicitly describe the molecular mechanism underlying each type of regulation and (iii) fully reference the collected data by cross-linking to existing databases. Since the accumulated data are valuable for researchers in diverse disciplines (such as pathology and pathophysiology, clinical laboratory diagnostics, medicinal biochemistry and drug design), M6AREG is expected to have many implications for the future conduct of m6A-based regulation studies. It is currently accessible by all users at: https://idrblab.org/m6areg/.

摘要

作为真核 RNA 中最普遍的内部修饰,N6-甲基腺苷(m6A)已被发现在细胞增殖、代谢稳态、胚胎发育等方面发挥重要作用。随着人们对 m6A 研究兴趣的迅速积累,其在疾病发展和药物反应调控中的关键作用越来越受到关注。因此,非常需要一个提供 m6A 调控相关有价值数据的数据库;然而,目前还没有这样的数据库。在此,我们开发了一个名为"M6AREG"的新数据库,(i)系统地涵盖 m6A 调控对疾病发展和药物反应的影响的数据,(ii)明确描述每种调控类型的分子机制,(iii)通过与现有数据库的交叉链接充分引用所收集的数据。由于积累的数据对病理学和病理生理学、临床实验室诊断、药用生物化学和药物设计等不同学科的研究人员都具有重要价值,因此 M6AREG 有望对未来的 m6A 调控研究产生重要影响。目前,所有用户均可通过以下网址访问该数据库:https://idrblab.org/m6areg/。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/1e62aa1c147d/gkac801fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/6bc4ce714f70/gkac801figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/8003e848c5fe/gkac801fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/fd20c0bf288b/gkac801fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/98a27c053010/gkac801fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/60b0f3a9c89e/gkac801fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/6276c51c7f98/gkac801fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/1e62aa1c147d/gkac801fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/6bc4ce714f70/gkac801figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/8003e848c5fe/gkac801fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/fd20c0bf288b/gkac801fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/98a27c053010/gkac801fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/60b0f3a9c89e/gkac801fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/6276c51c7f98/gkac801fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc78/9825441/1e62aa1c147d/gkac801fig6.jpg

相似文献

[1]
M6AREG: m6A-centered regulation of disease development and drug response.

Nucleic Acids Res. 2023-1-6

[2]
N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.

Front Oncol. 2021-10-15

[3]
N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.

Front Biosci (Landmark Ed). 2022-11-11

[4]
Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis.

Front Cell Dev Biol. 2022-6-30

[5]
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.

Int J Biol Sci. 2021

[6]
Potential roles of N6-methyladenosine (m6A) in immune cells.

J Transl Med. 2021-6-8

[7]
Functions of N6-methyladenosine and its role in cancer.

Mol Cancer. 2019-12-4

[8]
Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.

J Zhejiang Univ Sci B. 2020-7

[9]
Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.

J Clin Lab Anal. 2022-9

[10]
NPCDR: natural product-based drug combination and its disease-specific molecular regulation.

Nucleic Acids Res. 2022-1-7

引用本文的文献

[1]
mADP-GCNPUAS: mA-Disease Prediction via Graph Convolutional Network and Positive-Unlabeled Learning with Self-Adaptive Sampling.

Interdiscip Sci. 2025-8-30

[2]
Development of a prognostic model based on m6A reader upregulation and immune infiltration in multiple malignant tumors.

Transl Cancer Res. 2025-7-30

[3]
Multimodal zero-shot learning of previously unseen epitranscriptomes from RNA-seq data.

Brief Bioinform. 2025-7-2

[4]
TDP-43/ALKBH5-mediated mA modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1/S cell cycle transition.

MedComm (2020). 2025-2-18

[5]
Multichrome encoding-based multiplexed, spatially resolved imaging reveals single-cell RNA epigenetic modifications heterogeneity.

Nat Commun. 2025-1-22

[6]
The role of artificial intelligence in drug screening, drug design, and clinical trials.

Front Pharmacol. 2024-11-29

[7]
Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation.

Cell Genom. 2025-1-8

[8]
The role and mechanism of "eight famous herbals in Zhejiang" in cancer via network pharmacology and experimental validation.

Front Oncol. 2024-11-15

[9]
Clinical significance of the m6A methyltransferase METTL3 in peripheral blood of patients with coronary heart disease.

Front Cardiovasc Med. 2024-9-20

[10]
The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases.

Theranostics. 2024

本文引用的文献

[1]
REGLIV: Molecular regulation data of diverse living systems facilitating current multiomics research.

Comput Biol Med. 2022-9

[2]
Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.

Cancers (Basel). 2022-6-29

[3]
ConSIG: consistent discovery of molecular signature from OMIC data.

Brief Bioinform. 2022-7-18

[4]
FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis.

Proc Natl Acad Sci U S A. 2022-6-28

[5]
YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.

Clin Transl Med. 2022-6

[6]
mA RNA Modification in Gene Expression Regulation.

Genes (Basel). 2022-5-19

[7]
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.

Nat Commun. 2022-5-13

[8]
M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Mol Cancer. 2022-5-6

[9]
FTO mediates LINE1 mA demethylation and chromatin regulation in mESCs and mouse development.

Science. 2022-5-27

[10]
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment.

Mol Ther Nucleic Acids. 2022-4-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索